Lise Vanderkelen Nelson Labs - Qepler's Drug/Device Combination Products Summit 2018

Dr. Ir. Lise Vanderkelen

Department Head Pharma and Microbiology,
Nelson Labs Europe (formerly Toxikon Europe)
Tervuren, Belgium
Nelson Labs Europe - formerly Toxikon Europe

Lise Vanderkelen received her Ph.D. from the Faculty of Bioscience Engineering at the University of Leuven (Belgium) in 2012.

She started at Nelson Labs Europe (formerly Toxikon Europe) in 2013 as study director at the Extractables & Leachables Department, focusing on Injectables and Parenterals and in 2014 she became responsible for the chemical characterization testing for the medical device industry.

In 2016, she became Department Head Pharma Services at Nelson Labs Europe. The main focus of this department is identifying organic impurities in drug products as well as in use stability of drug-device combination.

In 2017, the scope expanded and includes now also all microbiological testing offered at Nelson Labs Europe.

Related Sessions:

DRUG/DEVICE COMBINATION
PRODUCTS SUMMIT 2018

  • 15-November-2018
  • Berlin, DE
  • Pharma
Day 2: Friday 16, November 2018
BLOCK: SAFETY EVALUATION AND CHEMICAL CHARACTERISATION.
CASE STUDY: Drug-device compatibility: Where is the guideline?
  • Interaction of drugs with materials.
  • In-use stability testing, how do test this?
  • Can this replace Extractables &Leachables testing?
  • Case studies.
View Details